Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of A neW Management Strategy for Patients With pArKinson's disEase usiNg an Innovative telemonitorING Device : AWAKENING Study

NCT06401395 is registered in ClinicalTrials.gov with DIAMPARK as lead sponsor.

NCT NCT06401395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06401395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of A neW Management Strategy for Patients With pArKinson's disEase usiNg an Innovative telemonitorING Device : AWAKENING Study
Lead sponsor
DIAMPARK
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2024
Completion date
August 1, 2027
Enrollment
300 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease